Oximeter ambient light cancellation

Abstract
A pulse oximeter method and apparatus which provides (1) a notch filter at a distance between a modulation frequency and a common multiple of commonly used power line frequencies (50, 60, 100 and 120) and also (2) a demodulation frequency greater than a highest pulse rate of a person and lower than any harmonic of 50, 60, 100 or 120 Hz, to filter ambient light interference, while choosing an optimum demodulation frequency that avoids interference from the notch filter or from harmonics of the line interference. Also, ambient light for any low frequency interference, such as power line interference, is measured both before and after each of the light emitter wavelengths and the average of the ambient light is then subtracted from the detected signal.
Description
BACKGROUND OF THE INVENTION

The present invention relates to oximeters, and in particular to techniques for ambient light cancellation in pulse oximeters.


Pulse oximetry is typically used to measure various blood flow characteristics including, but not limited to, the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and the rate of blood pulsations corresponding to each heartbeat of a patient. Measurement of these characteristics has been accomplished by use of a non-invasive sensor which scatters light through a portion of the patient's tissue where blood perfuses the tissue, and photoelectrically senses the absorption of light in such tissue. The amount of light absorbed is then used to calculate the amount of blood constituent being measured.


The light scattered through the tissue is selected to be of one or more wavelengths that are absorbed by the blood in an amount representative of the amount of the blood constituent present in the blood. The amount of transmitted light scattered through the tissue will vary in accordance with the changing amount of blood constituent in the tissue and the related light absorption. For measuring blood oxygen level, such sensors have typically been provided with a light source that is adapted to generate light of at least two different wavelengths, and with photodetectors sensitive to both of those wavelengths, in accordance with known techniques for measuring blood oxygen saturation.


Known non-invasive sensors include devices that are secured to a portion of the body, such as a finger, an ear or the scalp. In animals and humans, the tissue of these body portions is perfused with blood and the tissue surface is readily accessible to the sensor.


One problem with oximeter measurements is that in addition to receiving the light that was directed at the tissue, ambient light is also detected by the photodetector. Attempts can be made to block out ambient light, but some amount of ambient light will typically be detected. One particular concern is the light at the power line frequency of fluorescent or other lights, which is 60 Hz in the United States and 50 Hz in Europe and other countries.


Since a single photodetector is typically used, the light of different wavelengths, such as red and infrared, is time multiplexed. The detected signal must be demultiplexed. The demultiplexing frequency must be high enough so that it is much larger than the pulse rate. However, choosing a demultiplexing frequency is also impacted by the ambient light interference. One issue is the aliasing of harmonics of the AC power line frequency. U.S. Pat. No. 5,713,355 discusses a technique of altering the demultiplexing frequency depending upon the amount of ambient interference detected at each frequency.


U.S. Pat. No. 5,885,213 discusses subtracting a dark signal (detected ambient light) from the detected light signal. This is accomplished by leaving both the red and infrared light emitters off, in between turning them on, so that a “dark” signal supposedly composed of the ambient light present can be detected. This can then be subtracted from the desired signal. Other examples of patents dealing with the ambient light issue are U.S. Pat. No. 6,385,471, U.S. Pat. No. 5,846,190 and U.S. Pat. No. 4,781,195.


U.S. Pat. No. 6,449,501 discusses using a notch filter to filter out line frequency. However, the sampling rate is described as being set to twice the fundamental frequency of the power line interference, leaving higher harmonics of the power line interference as a problem, and it is unclear how the interference can be filtered without filtering the modulation frequency. Another example of a notch filter being used is set forth in U.S. Pat. No. 4,802,486, which uses a notch filter for the EKG signal.


BRIEF SUMMARY OF THE INVENTION

The present invention provides a pulse oximeter method and apparatus which provides (1) a notch filter at a distance between a demodulation frequency and a common multiple of commonly used power line frequencies (50, 60, 100, and 120) and also (2) a demodulation frequency greater than a highest pulse rate of a person and lower than any harmonic of 50, 60, 100, or 120 Hz. The invention thus allows the filtering of a significant source of ambient light interference, while choosing an optimum demodulation frequency that avoids interference from the notch filter or from harmonics of the power line interference.


In one embodiment, the common multiple is 1200, with the demodulation frequency being between 5 and 20 Hz away from 1200, preferably approximately 1211 in one embodiment.


In another aspect of the invention, dark signals, or ambient light, are measured both before and after each of the light emitter wavelengths (red and infrared in one embodiment). Instead of simply subtracting one of the dark levels, the two dark levels are averaged and then subtracted from the detected signal. This compensates for a variation in ambient light during the detected signal, reducing the effect of power line interference or any other low frequency interference.


In a another aspect of the present invention, digital filtering and decimation are done in the digital domain. When there is a change in a gain setting on the front end hardware, or in the LED power, the filters are preloaded to put values in their memory to correspond to an estimate of the settled value of the output at the new gain or power settings. This preloading speeds up when valid data will be available at the output of the filter.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of an oximeter incorporating the present invention.



FIG. 2 is a block diagram of a portion of the digital manipulations in one embodiment of the invention, including a notch filter.



FIG. 3 is a diagram illustrating the multiple dark levels that are averaged in an embodiment of the invention.



FIG. 4 is a diagram illustrating the preloading of the digital filter and decimator according to an embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Overall System



FIG. 1 illustrates an embodiment of an oximetry system incorporating the present invention. A sensor 10 includes red and infrared LEDs and a photodetector. These are connected by a cable 12 to a board 14. LED drive current is provided by an LED drive interface 16. The received photocurrent from the sensor is provided to an I-V interface 18. The IR and red voltages are then provided to a sigma-delta interface 20 incorporating the present invention. The output of sigma-delta interface 20 is provided to a microcontroller 22. Microcontroller 22 includes flash memory for a program, and EEPROM memory for data. The oximeter also includes a microprocessor chip 24 connected to a flash memory 26. Finally, a clock 28 is used and an interface 30 to a digital calibration in the sensor 10 is provided. A separate host 32 receives the processed information, as well as receiving an analog signal on a line 34 for providing an analog display.


Notch Filter



FIG. 2 shows an analog-to-digital converter 40 which provides a digital signal to be manipulated by microcontroller 22 of FIG. 1. The microprocessor would include a demodulator 42, four stages of filter/decimators 44, a low pass filter with a notch 46, as well as other blocks for digital manipulation of the signals and calculation of oxygen saturation as is well known in the art. Only the red channel is shown after the demodulation, but a similar channel is used for the IR signal.


Notch filter 46 deals with power line interference which, in the United States, comes from lights which operate on 60 Hz or 120 Hz, depending upon the power requirements. Europe and other areas use 50 Hz and 100 Hz. A common multiple of 50, 60, 100, and 120 Hz is 1200 Hz. The modulation bandwidth is chosen to be higher than the highest possible human pulse rate, preferably higher than 5 Hz. At the same time, it is chosen to be lower than any harmonic of the power line interference signals. Twenty hertz is chosen as a desirable upper limit because a second harmonic of 2450 will alias in at 2025 Hz. In one embodiment, the modulation frequency chosen is 1211.23 Hz. This is 11.23 Hz distant from 1200 Hz. (within a range of 5-20 Hz). Accordingly, in a preferred embodiment, a zero is provided in the notch filter at 11.23 Hz. The low pass filter with notch (46), in one embodiment, is an 8 pole Bessel filter with a notch at 11.25 Hz.


The present invention thus provides an effective means of eliminating interference from power line interference, such as the ripple on fluorescent lights which can alias onto the detected signal. Although anti-aliasing filters have been provided in hardware before a demodulator, it is difficult to make these effective, and thus there will be some residual line interference in the detected signal to be dealt with in the digital domain.


Averaging Ambient Dark Levels to Reduce Low Frequency Interference



FIG. 3 illustrates another aspect of the present invention, reducing ambient interference by averaging the ambient dark levels before and after a sampling period to account for low frequency interference from power lines or other sources. FIG. 3 shows a signal at a sampling rate of 2400. The upward sloping line in FIG. 3 is due to 60 Hz power line interference. It is desirable to eliminate the effect of this upward slope (which will be downward on other parts of the 60 Hz (or 50 Hz, etc.) signal.



FIG. 3 shows a detected signal during different periods of modulation. The detected signal level is illustrated by a line 50. During a first dark period 52, neither the red nor IR LED are on, allowing a sampling of the dark, or ambient, light. After this sampling, during a time period 54, the red LED is turned on, with signal 50 rising during this period as the red LED comes on to its full intensity. During the time period 56, the detected signal corresponds to the red LED being on.


After the red LED is turned off and the signal decays during a period 58, a second dark period 60 is sampled.


Subsequently, the IR LED is turned on during a period 62, and sampled during a period 64. It is turned off and the signal decays during a period 66, with a third dark sample being taken during a period 68. The third dark sample also corresponds to the first dark period 52, as the process repeats itself.


As can be seen from FIG. 3, if only one of the dark levels is used, an inaccurate ambient level may be measured if the ambient level is varying, such as due to a low frequency interference. By averaging the dark periods before and after the sampling period for a particular wavelength, a more accurate measurement of the ambient dark level signal is obtained. For example, the ambient interference during the red modulation period 56 is determined by measuring the dark 1 signal during period 52 and the dark 2 signal during period 60 and averaging these signals. Similarly, for the infrared modulation period 64, the dark 2 signal during period 60 and the dark 3 signal during period 68 are averaged and subtracted from the detected IR signal to eliminate the ambient interference. All of these calculations are done in the digital domain by microcontroller 22 of FIG. 1.


Preloading Decimation and Bessel Filters



FIG. 4 illustrates another aspect of the present invention where filters and software are preloaded. Before the analog input signal is processed through the sigma-delta modulator and multi-bit analog digital converter, it is typically amplified in a hardware amplifier 84. After processing by the sigma-delta modulator 86 and conversion into digital domain, it is decimated to reduce the sample rate by a decimator 88 and filtered by a Bessel filter 88. A controller 92 pre-loads the memories of the Bessel filter and decimator with an estimate of what the settled value of the output would be. This will significantly reduce the settling time of the fitter after a step change in its input. Such a step change in the input can occur from a change in the gain settings of the amplifier 84. Alternately, a step change can be the result of a change in the particular LED being activated, the power of the LED, or other gain settings of the front end hardware. Since the controller 92 would be activating such changes, it will have the knowledge of when to pre-load the filter and decimator with the appropriate values. Although these are shown as blocks in FIG. 4, it is understood that in the preferred embodiment this is done by a software program which functions as controller 92, filter 88 and decimator 90. This preloading of the filter and decimator provides that valid data is available sooner by shortening the settling time.


As will be understood by those skilled in the art, the present invention may be embodied in other specific forms without departing from the essential characteristics thereof. For example, more than two different wavelengths of light could be used. Alternately, a different demodulation frequency could be chosen. In addition, the notch filtering can be done either before or after other digital processing of the detected signal. Accordingly, the foregoing description is intended to be illustrative, but not limiting, of the scope of the invention which is set forth in the following claims.

Claims
  • 1. A pulse oximetry system comprising: an emitter capable of directing one or more wavelengths of light into a tissue;a detector capable of detecting the one or more wavelengths of light to provide an analog sensor signal;an amplifier configured to amplify the analog sensor signal to provide an amplified analog sensor signal;a sigma-delta modulator having an input coupled to receive the amplified analog sensor signal;a multiple bit analog-to-digital converter coupled to an output of the sigma-delta modulator to provide a digital signal;a decimator configured to receive the digital signal and output a decimated signal;a digital filter configured to operate on the decimated signal; anda controller configured to preload the decimator and digital filter with an estimate of a settled output value.
  • 2. The pulse oximetry system, as set forth in claim 1, wherein the amplifier comprises a hardware amplifier.
  • 3. The pulse oximetry system, as set forth in claim 1, wherein the digital filter comprises a Bessel filter.
  • 4. The pulse oximetry system, as set forth in claim 1, wherein the controller comprises a control program.
  • 5. The pulse oximetry system, as set forth in claim 1, wherein the controller is configured to preload the decimator and the digital filter after a step change in the decimated signal.
  • 6. The pulse oximetry system, as set forth in claim 1, wherein the controller is configured to preload the decimator and the digital filter in response to a change in a gain setting of the amplifier.
  • 7. The pulse oximetry system, as set forth in claim 1, wherein the controller is configured to preload the decimator and the digital filter in response to a change in an LED associated with the analog sensor signal being activated.
  • 8. The pulse oximetry system, as set forth in claim 1, wherein the controller is configured to preload the decimator and the digital filter in response to a power change in an LED associated with the analog sensor signal.
  • 9. The pulse oximetry system, as set forth in claim 1, wherein the controller is configured to preload the decimator and the digital filter in response to the controller changing a setting of the oximeter apparatus.
  • 10. A non-transitory computer-readable medium, comprising executable instructions for: controlling light at two wavelengths to be alternately driven into a tissue site using a modulation frequency that is a predetermined distance from a common multiple of 50, 60, 100, and 120, where the predetermined distance is greater than a highest pulse rate of a person and lower than a distance of any harmonic of 50, 60, 100, or 120;processing a signal received from the tissue site to generate a processed signal;notch filtering the processed signal at a frequency equivalent to the predetermined distance to produce a filtered signal; andcalculating at least one patient characteristic based on the filtered signal.
  • 11. The non-transitory computer-readable medium, as set forth in claim 10 wherein processing the received signal comprises digitizing the received signal.
  • 12. The non-transitory computer-readable medium, as set forth in claim 10 wherein the common multiple comprises 1200.
  • 13. The non-transitory computer-readable medium, as set forth in claim 10 wherein the predetermined distance is between 5 and 20 hertz.
  • 14. The non-transitory computer-readable medium, as set forth in claim 10 wherein the predetermined distance is approximately 11 hertz.
  • 15. The non-transitory computer-readable medium, as set forth in claim 10 wherein the notch filtering is performed by providing a zero in a digital filter at the predetermined distance.
  • 16. The non-transitory computer-readable medium, as set forth in claim 10 wherein calculating at least one patient characteristic comprises executable calculating a blood flow characteristic.
  • 17. A non-transitory computer-readable medium for measuring a detected light signal in a pulse oximeter, comprising executable instructions for: controlling light to be alternately driven into a tissue site using a modulation frequency to alternate between a first period of time when a first wavelength is being generated, a dark period of time when no light is being generated, and a second period of time when a second wavelength is being generated;estimating a first level of ambient light in a signal received from the tissue site during the first period of time by averaging detected light received during the dark periods before and after the first period;estimating a second level of ambient light in the signal received from the tissue site during the second period of time by averaging detected light received during the dark periods before and after the second period;calculating a total light signal by subtracting the first level of ambient light from the signal received from the tissue site generated during the first period of time and subtracting the second level of ambient light from the signal received from the tissue site generated during the second period of time; andcalculating at least one patient characteristic based on the total light signal.
  • 18. The non-transitory computer-readable medium, as set forth in claim 17 wherein calculating at least one patient characteristic comprises calculating a blood flow characteristic.
  • 19. The non-transitory computer-readable medium, as set forth in claim 17 wherein calculating at least one patient characteristic comprises calculating an oxygen saturation.
  • 20. The non-transitory computer-readable medium, as set forth in claim 17 wherein calculating at least one patient characteristic comprises calculating a pulse rate.
Parent Case Info

This application is a continuation of Ser. No. 11/495,415, filed Jul. 28, 2006, now U.S. Pat. No. 7,400,919, which is a divisional of Ser. No. 10/787,854, filed Feb. 25, 2004, [which is a continuation of Ser. No. 11/495,415 filed Jul. 28, 2006] now U.S. Pat. No. 7,190,985.

US Referenced Citations (255)
Number Name Date Kind
3638640 Shaw Feb 1972 A
4714341 Hamaguri et al. Dec 1987 A
4781195 Martin Nov 1988 A
4800885 Johnson Jan 1989 A
4802486 Goodman et al. Feb 1989 A
4805623 Jöbsis Feb 1989 A
4807630 Malinouskas Feb 1989 A
4807631 Hersh et al. Feb 1989 A
4848901 Hood, Jr. Jul 1989 A
4863265 Flower et al. Sep 1989 A
4911167 Corenman et al. Mar 1990 A
4913150 Cheung et al. Apr 1990 A
4928692 Goodman et al. May 1990 A
4934372 Corenman et al. Jun 1990 A
4936679 Mersch Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4948248 Lehman Aug 1990 A
4971062 Hasebe et al. Nov 1990 A
4972331 Chance Nov 1990 A
4974591 Awazu et al. Dec 1990 A
5028787 Rosenthal et al. Jul 1991 A
5065749 Hasebe et al. Nov 1991 A
5084327 Stengel Jan 1992 A
5119815 Chance Jun 1992 A
5122974 Chance Jun 1992 A
5167230 Chance Dec 1992 A
5190038 Polson et al. Mar 1993 A
5246003 DeLonzor Sep 1993 A
5247931 Norwood Sep 1993 A
5263244 Centa et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5279295 Martens et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5348004 Hollub Sep 1994 A
5349952 McCarthy et al. Sep 1994 A
5351685 Potratz Oct 1994 A
5355880 Thomas et al. Oct 1994 A
5368026 Swedlow et al. Nov 1994 A
5368224 Richardson et al. Nov 1994 A
5372136 Steuer et al. Dec 1994 A
5385143 Aoyagi Jan 1995 A
5390670 Centa et al. Feb 1995 A
5413099 Schmidt et al. May 1995 A
5469845 DeLonzor et al. Nov 1995 A
5482036 Diab et al. Jan 1996 A
5483646 Uchikoga Jan 1996 A
5533507 Potratz Jul 1996 A
5553614 Chance Sep 1996 A
5555882 Richardson et al. Sep 1996 A
5564417 Chance Oct 1996 A
5575284 Athan et al. Nov 1996 A
5575285 Takanashi et al. Nov 1996 A
5577500 Potratz Nov 1996 A
5611337 Bukta Mar 1997 A
5630413 Thomas et al. May 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5662106 Swedlow et al. Sep 1997 A
5676141 Hollub Oct 1997 A
5680857 Pelikan et al. Oct 1997 A
5692503 Keunstner Dec 1997 A
5713355 Richardson et al. Feb 1998 A
5730124 Yamauchi Mar 1998 A
5746697 Swedlow et al. May 1998 A
5758644 Diab et al. Jun 1998 A
5779631 Chance Jul 1998 A
5782757 Diab et al. Jul 1998 A
5786592 Hök Jul 1998 A
5803910 Potratz Sep 1998 A
5830136 DeLonzor et al. Nov 1998 A
5830139 Abreu Nov 1998 A
5831598 Kauffert et al. Nov 1998 A
5842981 Larsen et al. Dec 1998 A
5846190 Woehrle Dec 1998 A
5871442 Madarasz et al. Feb 1999 A
5873821 Chance et al. Feb 1999 A
5885213 Richardson et al. Mar 1999 A
5919134 Diab Jul 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5921921 Potratz et al. Jul 1999 A
5924979 Swedlow et al. Jul 1999 A
5954644 Dettling et al. Sep 1999 A
5995855 Kiani et al. Nov 1999 A
5995856 Mannheimer et al. Nov 1999 A
5995859 Takahashi Nov 1999 A
6011985 Athan et al. Jan 2000 A
6011986 Diab et al. Jan 2000 A
6064898 Aldrich May 2000 A
6081742 Amano et al. Jun 2000 A
6088607 Diab et al. Jul 2000 A
6120460 Abreu Sep 2000 A
6150951 Olejniczak Nov 2000 A
6154667 Miura et al. Nov 2000 A
6163715 Larsen et al. Dec 2000 A
6181958 Steuer et al. Jan 2001 B1
6181959 Schöllermann et al. Jan 2001 B1
6226539 Potratz May 2001 B1
6229856 Diab et al. May 2001 B1
6230035 Aoyagi et al. May 2001 B1
6266546 Steuer et al. Jul 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6312393 Abreu Nov 2001 B1
6353750 Kimura et al. Mar 2002 B1
6385471 Mortz May 2002 B1
6397091 Diab et al. May 2002 B2
6397092 Norris et al. May 2002 B1
6415236 Kobayashi et al. Jul 2002 B2
6419671 Lemberg Jul 2002 B1
6438399 Kurth Aug 2002 B1
6449501 Reuss Sep 2002 B1
6461305 Schnall Oct 2002 B1
6466809 Riley Oct 2002 B1
6487439 Skladnev et al. Nov 2002 B1
6496711 Athan et al. Dec 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6505133 Hanna et al. Jan 2003 B1
6526301 Larsen et al. Feb 2003 B2
6544193 Abreu Apr 2003 B2
6546267 Sugiura et al. Apr 2003 B1
6549795 Chance Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6591122 Schmitt Jul 2003 B2
6594513 Jobsis et al. Jul 2003 B1
6596016 Vreman et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6606511 Ali et al. Aug 2003 B1
6615064 Aldrich Sep 2003 B1
6618042 Powell Sep 2003 B1
6622095 Kobayashi et al. Sep 2003 B2
6643530 Diab et al. Nov 2003 B2
6654621 Palatnik et al. Nov 2003 B2
6654624 Diab et al. Nov 2003 B2
6658276 Pishney et al. Dec 2003 B2
6658277 Wasserman Dec 2003 B2
6662030 Khalil et al. Dec 2003 B2
6668183 Hicks et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671528 Steuer et al. Dec 2003 B2
6678543 Diab et al. Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6690958 Walker et al. Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
6708048 Chance Mar 2004 B1
6711424 Fine et al. Mar 2004 B1
6711425 Reuss Mar 2004 B1
6714245 Ono Mar 2004 B1
6731274 Powell May 2004 B2
6748253 Norris et al. Jun 2004 B2
6778923 Norris et al. Aug 2004 B2
6785568 Chance Aug 2004 B2
6793654 Lemberg Sep 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801798 Geddes et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6829496 Nagai et al. Dec 2004 B2
6850053 Daalmans et al. Feb 2005 B2
6863652 Huang et al. Mar 2005 B2
6873865 Steuer et al. Mar 2005 B2
6889153 Dietiker May 2005 B2
6898451 Wuori May 2005 B2
6930608 Grajales et al. Aug 2005 B2
6939307 Dunlop Sep 2005 B1
6947780 Scharf Sep 2005 B2
6949081 Chance Sep 2005 B1
6961598 Diab Nov 2005 B2
6983178 Fine et al. Jan 2006 B2
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
7003339 Diab et al. Feb 2006 B2
7024235 Melker et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7030749 Al-Ali Apr 2006 B2
7035697 Brown Apr 2006 B1
7047054 Benni May 2006 B2
7047056 Hannula et al. May 2006 B2
7062307 Norris et al. Jun 2006 B2
7127278 Melker et al. Oct 2006 B2
7162306 Caby et al. Jan 2007 B2
7209775 Bae et al. Apr 2007 B2
7221971 Diab et al. May 2007 B2
7236811 Schmitt Jun 2007 B2
7263395 Chan et al. Aug 2007 B2
7272426 Schmid Sep 2007 B2
7302284 Baker, Jr. et al. Nov 2007 B2
7313427 Benni Dec 2007 B2
7315753 Baker, Jr. et al. Jan 2008 B2
7336983 Baker, Jr. et al. Feb 2008 B2
7373193 Al-Ali et al. May 2008 B2
7500950 Al-Ali et al. Mar 2009 B2
20010002206 Diab et al. May 2001 A1
20010005773 Larsen et al. Jun 2001 A1
20010020122 Steuer et al. Sep 2001 A1
20010039376 Steuer et al. Nov 2001 A1
20010044700 Kobayashi et al. Nov 2001 A1
20020026106 Khalil et al. Feb 2002 A1
20020035318 Mannheimer et al. Mar 2002 A1
20020038079 Steuer et al. Mar 2002 A1
20020042558 Mendelson Apr 2002 A1
20020049389 Abreu Apr 2002 A1
20020062071 Diab et al. May 2002 A1
20020068859 Knopp Jun 2002 A1
20020111748 Kobayashi et al. Aug 2002 A1
20020133068 Huiku Sep 2002 A1
20020156354 Larson Oct 2002 A1
20020161287 Schmitt Oct 2002 A1
20020161290 Chance Oct 2002 A1
20020165439 Schmitt Nov 2002 A1
20020198443 Ting Dec 2002 A1
20030023140 Chance Jan 2003 A1
20030028357 Norris et al. Feb 2003 A1
20030055324 Wasserman Mar 2003 A1
20030060693 Monfre et al. Mar 2003 A1
20030139687 Abreu Jul 2003 A1
20030144584 Mendelson Jul 2003 A1
20030220548 Schmitt Nov 2003 A1
20030220576 Diab Nov 2003 A1
20040010188 Wasserman Jan 2004 A1
20040054270 Pewzner et al. Mar 2004 A1
20040087846 Wasserman May 2004 A1
20040107065 Al-Ali Jun 2004 A1
20040127779 Steuer et al. Jul 2004 A1
20040152965 Diab et al. Aug 2004 A1
20040171920 Mannheimer et al. Sep 2004 A1
20040176670 Takamura et al. Sep 2004 A1
20040176671 Fine et al. Sep 2004 A1
20040230106 Schmitt et al. Nov 2004 A1
20050020894 Norris et al. Jan 2005 A1
20050075548 Al-Ali et al. Apr 2005 A1
20050080323 Kato Apr 2005 A1
20050101850 Parker May 2005 A1
20050113651 Wood et al. May 2005 A1
20050113656 Chance May 2005 A1
20050143634 Baker, Jr. et al. Jun 2005 A1
20050168722 Forstner et al. Aug 2005 A1
20050177034 Beaumont Aug 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050203357 Debreczeny et al. Sep 2005 A1
20050228248 Dietiker Oct 2005 A1
20050267346 Faber et al. Dec 2005 A1
20050283059 Iyer et al. Dec 2005 A1
20060009688 Lamego et al. Jan 2006 A1
20060015021 Cheng Jan 2006 A1
20060020181 Schmitt Jan 2006 A1
20060030763 Mannheimer et al. Feb 2006 A1
20060052680 Diab Mar 2006 A1
20060058683 Chance Mar 2006 A1
20060064024 Schnall Mar 2006 A1
20060195028 Hannula et al. Aug 2006 A1
20060224058 Mannheimer Oct 2006 A1
20060247501 Ali Nov 2006 A1
20060258921 Addison et al. Nov 2006 A1
20070225582 Diab et al. Sep 2007 A1
20080017800 Benni Jan 2008 A1
20080033265 Diab et al. Feb 2008 A1
Foreign Referenced Citations (26)
Number Date Country
19647877 May 1998 DE
194105 May 1991 EP
1491135 Dec 2004 EP
3170866 Jul 1991 JP
3238813 Oct 1991 JP
7124138 May 1995 JP
7136150 May 1995 JP
3116255 Dec 2000 JP
22224088 Aug 2002 JP
23153881 May 2003 JP
23153882 May 2003 JP
2003194714 Jul 2003 JP
2003210438 Jul 2003 JP
2004008572 Jan 2004 JP
2004113353 Apr 2004 JP
2004194908 Jul 2004 JP
24261364 Sep 2004 JP
2004248819 Sep 2004 JP
2004290545 Oct 2004 JP
24329928 Nov 2004 JP
WO9101678 Feb 1991 WO
WO9309711 May 1993 WO
WO9843071 Oct 1998 WO
WO9932030 Jul 1999 WO
WO0021438 Apr 2000 WO
WO2005009221 Feb 2005 WO
Related Publications (1)
Number Date Country
20090005662 A1 Jan 2009 US
Divisions (1)
Number Date Country
Parent 10787854 Feb 2004 US
Child 11495415 US
Continuations (1)
Number Date Country
Parent 11495415 Jul 2006 US
Child 12172981 US